May 1, 2017

FDA OKs immune-boosting drug for advanced bladder cancer

by The Associated Press

FDA OKs immune-boosting drug for advanced bladder cancer
This image provided by AstraZeneca shows the company's drug Imfinzi, known chemically as durvalumab. On Monday, May 1, 2017, the Food and Drug Administration approved Imfinzi, part of the new generation of immuno-oncology drugs, which help the immune system to fight off cancer. The FDA also approved a companion diagnostic test for identifying which patients are most likely to benefit from the drug. (AstraZeneca via AP)

U.S. regulators have approved a new drug that harnesses the immune system to treat advanced bladder cancer.

The Food and Drug Administration on Monday approved Imfinzi (IM'-fin-zee) along with a companion diagnostic test for identifying which patients are most likely to benefit from it.

Imfinzi, also known as durvalumab, is part of a of drugs which stimulate the immune system to help fight cancer.

AstraZeneca, Imfinzi's developer, says the average monthly list price for the drug is roughly $15,000, but varies with the patient's weight. It's given by IV every two weeks.

Bladder cancer is the sixth most common type of cancer in the U.S., and is usually fatal when it recurs.

AstraZeneca is testing the drug against numerous cancers.

© 2017 The Associated Press. All rights reserved.

Citation: FDA OKs immune-boosting drug for advanced bladder cancer (2017, May 1) retrieved 28 April 2024 from https://medicalxpress.com/news/2017-05-fda-oks-immune-boosting-drug-advanced.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

FDA OKs immunotherapy drugs for bladder, blood cancers (Update)
2 shares

Feedback to editors
Research shows 'profound' link between dietary choices and brain health

20 hours ago
Component of keto diet plus immunotherapy may reduce prostate cancer

Apr 27, 2024
Study finds big jump in addiction treatment at community health clinics

Apr 27, 2024
Positive childhood experiences can boost mental health and reduce depression and anxiety in teens

Apr 27, 2024
Gene linked to epilepsy and autism decoded in new study

Apr 26, 2024
Blood test finds knee osteoarthritis up to eight years before it appears on X-rays

Apr 26, 2024
Researchers find pregnancy cytokine levels impact fetal brain development and offspring behavior

Apr 26, 2024
Study finds biomarkers for psychiatric symptoms in patients with rare genetic condition 22q

Apr 26, 2024
Clinical trial evaluates azithromycin for preventing chronic lung disease in premature babies

Apr 26, 2024
Scientists report that new gene therapy slows down amyotrophic lateral sclerosis disease progression

Apr 26, 2024
Load comments (0)